Systemic Mastocytosis With Associated Clonal Hematological Non-Mast Cell Lineage Disorder (MDS-RCMD): A Difficult Disease to Diagnose and Treat

Indian Journal of Hematology and Blood Transfusion - India
doi 10.1007/s12288-015-0594-2
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Systemic Mastocytosis With Associated Clonal Haematological Non-Mast Cell Lineage Diseases: A Histopathological Challenge

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2004English

Omalizumab and Systemic Mast Cell Activation Diseases: A Treatment Opportunity for Non-Clonal Disorder?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Skin Lesions Difficult to Diagnose or Treat for Pediatricians

Journal of Contemporary Medicine
2019English

AB0916 Whipple Disease: A Rare Disease Difficult to Diagnose

2017English

Systemic Mastocytosis (SM) and Mast Cell Activation Syndrome (MCAS); How Do They Differ?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Comparing Histamine Intolerance and Non-Clonal Mast Cell Activation Syndrome

Intestinal Research
Gastroenterology
2020English

Siglec-8 as a Drugable Target to Treat Eosinophil and Mast Cell-Associated Conditions

Pharmacology and Therapeutics
Pharmacology
2012English

Pulmonary Manifestation of Systemic Mast Cell Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2000English

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) — How to Diagnose and Treat?

Nowotwory
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy